Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
•
Anticoagulation
How would you manage a patient with new DVT while on dabigatran for atrial fibrillation who may have missed some doses of dabigatran around time of DVT?
- No high risk factors for DVT
- Is this considered anticoagulation failure?
Related Questions
How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?
How do you approach the management of PFO in a young person with a cryptogenic CVA?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
In extremely obese patients with spontaneous DVT/PE who have been anticoagulated for > 6 months, do you feel comfortable reducing the DOAC to prophylactic dose or do you prefer continuing full dose indefinite anticoagulation?
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
Would you recommend indefinite anticoagulation in any scenario of a provoked clot?
Are SCDs contraindicated in patients with acute DVTs?
For a patient with ESRD on hemodialysis with recurrent AV fistula thrombosis and a finding of Protein C deficiency based on decreased plasma activity level on thrombophilia workup, what is recommended in terms of anticoagulation management?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?